Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma

Anticancer Research

Volumn 28, Issue 3 A, 2008, Pages 1565-1569

  Bozzi, Fabio ^a   Collini, Paola ^a   Aiello, Antonella ^a   Barzanò, Elena ^a   Gambirasio, Felicita ^a   Podda, Marta ^a   Meazza, Cristina ^a   Ferrari, Andrea ^a   Luksch, Roberto ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Flow cytometry; Immunophenotyping; Neuroblastoma; Rhabdomyosarcoma

Indexed keywords

CD45 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; THY 1 ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CHILD; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFANT; NEUROBLASTOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

BONE MARROW NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HUMANS; NEOPLASM CIRCULATING CELLS; NEOPLASM STAGING; NEUROBLASTOMA; PHENOTYPE; RHABDOMYOSARCOMA; RNA, NEOPLASM;

EID: 45949093849     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Swerts K, De Moerloose B, Dhooge C. Brichard B, Benoit Y, Laureys G and Philippe J: Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry. Cytometry B Clin Cytom 61:9-19, 2004.
2. Dagher R and Helman L: Rhabdomyosarcoma: an overview. Oncologist 4: 34-44, 1999.
3. Michelagnoli MP, Burchill SA, Cullinane C, Selby PJ and Lewis IJ: Myogenin - a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1. Med Pediatr Oncol 40: 1-8, 2003.
4. Lanier LL, Testi R, Bindl J and Phillips JH: Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 169: 2233-2238, 1989.
5. Mechtersheimer G, Staudter M and Moller P: Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res 51: 1300-1307, 1991.
6. Chang A, Benda PM, Wood BL and Kussick SJ: Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry. Am J Clin Pathol 119: 643-655, 2003.
7. Fiegel HC, Kaifi JT, Quaas A, Varol E, Krickhahn A, Metzger R, Sauter G, Holger T, Izbicki JR, Erttmann R and Kluth D: Lack of Thy1 (CD90) expression in neuroblastoma is correlated with impaired survival. Pediatric Surg Int 24: 101-105, 2008.
8. Michels S, Swanson PE, Robb JA and Wick MR: Leu-7 in small cell neoplasms. An immunohistochemical study with ultrastructural correlations. Cancer 60: 2958-2964, 1987.
9. Bozzi F, Gambirasio F, Luksch R, Collini P, Brando B and Fossati Bellani F: Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma with flow cytometry. Anticancer Res 26: 3281-3288, 2006.
10. Bozzi F, Luksch R, Collini P. Gambirasio F, Barzano E, Polastri D, Podda M, Brando B and Fossati-Bellani F: Molecular detection of dopamine decarboxylase expression by means of reverse transcriptase and polymerase chain reaction in bone marrow and peripheral blood: utility as a tumor marker for neuroblastoma. Diagn Mol Pathol 13: 135-143, 2004.
11. Linardic CM, Downie DL, Qualman S, Bendey RC and Counter CM: Genetic modeling of human rhadbomyosarcoma. Cancer Res 65: 4490-4495, 2005.
12. Hansford LM, McKee AE, Zhang L, George RE, Gerstle, JT, Thorner PS, Smith KM, Look T, Yeger H, Miller FD, Irwin MS, Thiele CJ and Kaplan DR: Neuroblastoma cells isolated from marrow metastases contain a naturally enricedh tumor-initiating cells. Cancer Res 67: 11234-11243, 2007.
13. Rege TA and Hagood JS: Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer and fibrosis. The Faseb Journal 20: 1045-1054, 2006.
14. Burchill SA, Lewis IJ, Abrams KR, Riley R, Imeson J, Pearson AD, Pinkerton R and Selby P: Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol 19: 1795-801, 2001.